title: Fulminant tumefactive multiple sclerosis: therapeutic implications of histopathology.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Haupts
authors.forename: Sebastian K
authors.initials: SK
authors.lastname: Schimrigk
authors.forename: Nils
authors.initials: N
authors.lastname: Brune
authors.forename: Andrew
authors.initials: A
authors.lastname: Chan
authors.forename: Guido
authors.initials: G
authors.lastname: Ahle
authors.forename: Kerstin
authors.initials: K
authors.lastname: Hellwig
authors.forename: Fatima B
authors.initials: FB
authors.lastname: König
authors.forename: Uwe
authors.initials: U
authors.lastname: Schlegel
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Brück
authors.forename: Ralf
authors.initials: R
authors.lastname: Gold
mesh_terms: D000328:Adult; D018826:CD13 Antigens / Q000378:metabolism; D040502:Calgranulin B / Q000378:metabolism; D003711:Demyelinating Diseases / Q000209:etiology* / Q000473:pathology*; D005260:Female; D006801:Humans; D008264:Macrophages / Q000378:metabolism / Q000473:pathology; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000150:complications* / Q000473:pathology* / Q000628:therapy; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein / Q000378:metabolism; D063308:Myelin-Oligodendrocyte Glycoprotein
chemical_list: D040502:Calgranulin B; C571326:MOG protein, human; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein; D018826:CD13 Antigens